This book reviews the descriptive features of psychotic symptoms in various medical conditions (psychiatric, early psychosis, general medical, neurological and dementia), non-medical settings (individuals without the need for care or at high risk for psychosis) and age groups (children and adolescents, adults, older adults). Similarly, the perspectives of many disciplines are provided (history, psychiatry, psychology, psychopathology, neurology, phenomenological philosophy) so that readers may become familiar with different approaches that are used to define, evaluate and categorize psychosis, at times independently of clinical diagnosis. This book is a resource book for those requiring an understanding of clinical and conceptual issues associated with psychosis, with chapters written by academics and clinicians who are leaders in their respective fields. The book also provides a guide regarding the methods of assessment for psychosis and its symptoms, with 120 rating scales, which are described and evaluated. The Assessment of Psychosis will be particularly useful to the clinical and research community, but also to readers interested in individual differences and human psychopathology.

This book highlights recent research investigating psychological and neural mechanisms contributing to dysfunctional cognition in people with schizophrenia. The work on cognition in schizophrenia from the past 20 years is highlighted, and emphasis throughout the book is placed on utilizing the Research Domain Criterion framework. Thus, the book also covers animals work relevant to schizophrenia that assesses behaviors utilizing the same framework, enabling mechanistic studies and highlighting potential biomarkers of function. The book also includes important areas of research in the field of cognitive function in schizophrenia that have received less attention, such as cognitive side-effects of current treatments and olfactory-based cognition. Altogether, the book provides a translational perspective of the most-up-to-date research on cognition in schizophrenia to-date, but with identification of novel directions for research initiatives..

This book explores the relationship between schizophrenia and common sense. It approaches this theme from a multidisciplinary perspective. Coverage features contributions from phenomenology, cognitive neuroscience, philosophy of mind, psychology, and social cognition. The contributors address the following questions: How relevant is the loss of common sense in schizophrenia? How can the study of schizophrenia contribute to the study of common sense? How to understand and explain this loss of common sense? They also consider: What is the relationship of practical reasoning and logical formal reasoning with schizophrenia? What is the relationship between the person with a diagnosis of schizophrenia and social values? Chapters examine such issues as rationality, emotions, self, and delusion. In addition, one looks at brain structure and neurotransmission. Others explore phenomenological and Wittgensteinian theories. The book features papers from the Schizophrenia and Common Sense International Workshop, held at New University of Lisbon, November 2015. It offers new insights into this topic and will appeal to researchers, students, as well as interested general readers.

Because of the complex range of factors to be considered in pscyhosis –genetic, neurologic, biologic, environmental, family, culture - this issue of Child and Adolescent Psychiatric Clinics presents aspects that have the greatest relevance and impact in diagnosing and treating child and adolescent patients. Among some of the topics covered: Schizophrenia, Affective disorders and Psychosis, Comorbid diseases, Neurocognition, Genetics, Neuroimaging findings, and Treatment approaches of Psychopharmacology, Psychotherapy, and Community Rehabilitation. Jean Frazier, an expert in child and adolescent neuropsychiatry and in child psychopharmacology, leads this issue along with Yael Dvir, whose research and clinical interests include childhood psychosis and the associations between childhood psychosis and Autistic Spectrum Disorders.

This handbook examines state-of-the-art research and clinical findings on attenuated psychosis syndrome (APS) across the globe. It addresses symptoms, assessment methods, and treatment approaches as they differ and converge across countries and cultures. The handbook explores how the illness impairs many aspects of daily functioning, with high rates of suicide and a reduced life span. It details how early detection is critical and may greatly reduce the public health burden of the illness. Chapters describe the early identification and intervention efforts that are currently underway across the world. The book offers international findings from prominent researchers, elaborating culturally relevant illness symptoms, help-seeking behaviors, and assessment and intervention strategies. In addition, chapters illustrate wide variations in symptom expression and experience, reinforcing the necessity of culturally attuned practice in patient-centered care. The book concludes by examining the implications – challenges and opportunities – for future research and clinical practices from an international perspective. Topics featured in the Handbook include: Barriers to service in low-resourced countries. The role of traditional or culturally acceptable care in developing early intervention models. The reliability and validity of tools for assessing and identifying APS. Possible medical diagnoses that can present with APS symptoms and how to differentiate these conditions from APS. /divThe Handbook of Attenuated Psychosis Syndrome Across Cultures is a must-have resource for researchers, professors, clinicians, and related professionals as well as graduate students in child and school psychology, psychiatry, social work, and related disciplines.

Several alterations of brain function cause common mental problems in young people. ADHD, autism, tic disorders, learning difficulties, intellectual disability, and the psychotic disorders of young people are conventionally classified and described as discrete neuropsychiatric problems. Research, however, has made it clear that they are complex, variable, dimensional, overlapping, and that they frequently coexist and share aetiological influences. Developmental Neuropsychiatry explores how clinicians often find themselves confronted with complex problems of diagnosis and treatment. Existing texts and guidelines, however, continue to be organized around simple conceptualization of illness categories. The book provides unified accounts of the complex psychiatric, psychological, neurological, medical, social, and educational issues that are relevant to clinical understanding.

A few disorders have some of the same symptoms as schizophrenia including schizoaffective disorders, schizophreniform disorder, schizotypal and schizoid personality disorders, delusional disorder, and autism (schizophrenia spectrum disorders). Since the 2000 there has been significant progress in our understanding of the early presentations, assessment, suspected neuropathology, and treatment of these disorders. Recent technological breakthroughs in basic sciences hold promise for advancing our understanding of the pathophysiology of schizophrenia spectrum disorders. This collective monograph reviewers recent researches regarding the origins, onset, course, and outcome of schizophrenia spectrum disorders. In particular, this book will be illustrate new developments in terms of conceptual models, and research methodology, genetics and genomics, brain imaging and neurochemical studies, neurophysiology and information processing in schizophrenia spectrum disorders patients. Also will be highlighted new developments in our understanding of the childhood psychosis, prodromal and first-episode states, in treatment and rehabilitation. Thus, the purpose of this book is to provide up-to-date overview of the rapid advances made in the clinical and basic science studies supporting our understanding of the relationship between cerebral processes and clinical, cognitive and other presentations of the schizophrenia spectrum disorders. In addition, this book aims to monitor important research developments, which may be relevant to treatment, and rehabilitation of patients.

Advances in pharmacotherapy and psychosocial interventions continue to improve the success of managing schizophrenia. Early detection and intervention in people with, or at risk for, psychosis give patients and their families hope for a better course of illness and an improved outcome. The interdisciplinary approach, combining pharmacotherapy and psychosocial interventions, markedly increases the chance of long-lasting remission and recovery. However, a cure for schizophrenia has yet to be found. Research, particularly in the past decade, has revealed some of the biological and genetic facets of the origins of schizophrenia, and this has contributed to the better quality of treatment. This book aims to provide a short but detailed overview of current standards of care in schizophrenia. It takes into consideration several treatment recommendations proposed in published guidelines for schizophrenia, including the guidelines by the National Institute for Health and Clinical Excellence (2009), the American Psychiatric Association (2004), the Canadian Psychiatric Association (2005), and the Royal Australian and New Zealand College of Psychiatrists (2005). A major problem with guidelines such as these is the difficulties encountered in translating them into daily clinical practice. Therefore, the fundamental aim of this book is to present the guidelines as clearly as possible in the context of relevant clinical treatment issues. The book does this with the help of figures that provide the clinician with algorithms and summaries of the most important information required for the practical treatment and theoretical understanding of schizophrenia.